Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas

Cancer research has mainly focused on alterations of genes and proteins in cancer cells themselves that result in either gain-of-function in oncogenes or loss-of-function in tumour-suppressor genes. However, stromal variables within or around tumours, including blood and lymph vessels, stromal cells and various proteins, have also important impacts on tumour development and progression. It has been shown that disruption of stromal-epithelial interactions influences cellular proliferation, differentiation, death, motility, genomic integrity, angiogenesis, and other phenotypes in various tissues. Moreover, stromal variables are also critical to therapy in cancer patients. In this review, we mainly focus on the clinicopathological significance of stromal variables including angiogenesis, lymphangiogenesis, inflammatory infiltration, matrix metalloproteinase (MMP), and the particularly interesting new cysteine-histidine rich protein (PINCH) in colorectal cancer (CRC).

[1]  A. Giatromanolaki,et al.  Tumour angiogenesis: vascular growth and survival , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[2]  S. Kitano,et al.  Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  S. Zucker,et al.  Role of matrix metalloproteinases (MMPs) in colorectal cancer , 2004, Cancer and Metastasis Reviews.

[4]  V. Catalano,et al.  Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  J. Melkko,et al.  Inflammation and prognosis in colorectal cancer. , 2005, European journal of cancer.

[6]  G. Nicolson,et al.  Effects of mast cell-macrophage interactions on the production of collagenolytic enzymes by metastatic tumor cells and tumor-derived and stromal fibroblasts , 2004, Clinical & Experimental Metastasis.

[7]  Stephen J. Weiss,et al.  Furin-dependent intracellular activation of the human stromelysin-3 zymogen , 1995, Nature.

[8]  Xiao-Feng Sun,et al.  Stromal staining for PINCH is an independent prognostic indicator in colorectal cancer. , 2004, Neoplasia.

[9]  G. Bovo,et al.  Pre-operative interleukin-2 immunotherapy induces eosinophilic infiltration in colorectal neoplastic stroma. , 1995, Pathologica.

[10]  C. R. Teixeira,et al.  Angiogenesis in advanced colorectal adenocarcinoma with special reference to tumoral invasion. , 2002, Arquivos de gastroenterologia.

[11]  P. Hewett,et al.  Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. , 2002, Cancer research.

[12]  M. Tachibana,et al.  Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  G. Vrensen,et al.  In Vivo Angiogenic Phenotype of Endothelial Cells and Pericytes Induced by Vascular Endothelial Growth Factor-A , 2004, Journal of Histochemistry and Cytochemistry.

[14]  Yuan Li,et al.  Clinicopathologic and prognostic significance of MMP-7 (matrilysin) expression in human rectal cancer. , 2005, Japanese journal of clinical oncology.

[15]  Y. Fukushima,et al.  Xenografts of human solid tumors frequently express cellular-associated isoform of vascular endothelial growth factor (VEGF) 189. , 1999, Oncology reports.

[16]  D. Carbone,et al.  Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells , 1996, Nature Medicine.

[17]  K. Shirouzu,et al.  The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer , 2006, Cancer Chemotherapy and Pharmacology.

[18]  C. Turner,et al.  Paxillin: a new vinculin-binding protein present in focal adhesions , 1990, The Journal of cell biology.

[19]  M. Fernández-Aceñero,et al.  Prognostic influence of tumor‐associated eosinophilic infiltrate in colorectal carcinoma , 2000, Cancer.

[20]  K. Nabeshima,et al.  Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. , 1999, The American journal of pathology.

[21]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[22]  P. Chambon,et al.  Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review , 2005, Breast Cancer Research and Treatment.

[23]  K. Yano,et al.  Matrix Metalloproteinase-7 Facilitates Insulin-Like Growth Factor Bioavailability through Its Proteinase Activity on Insulin-Like Growth Factor Binding Protein 3 , 2004, Cancer Research.

[24]  K. O'Byrne,et al.  Angiogenesis and the immune response as targets for the prevention and treatment of colorectal cancer (review). , 2003, Oncology reports.

[25]  C. McArdle,et al.  The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer , 2005, British Journal of Cancer.

[26]  M. A. Sáez,et al.  The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma , 1997, Cancer.

[27]  R. Grenman,et al.  Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells , 2002, Oncogene.

[28]  Hiroyuki Yamamoto,et al.  Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer. , 2003, Carcinogenesis.

[29]  Stephen B Fox,et al.  The angiogenic switch for vascular endothelial growth factor (VEGF)‐A, VEGF‐B, VEGF‐C, and VEGF‐D in the adenoma–carcinoma sequence during colorectal cancer progression , 2003, The Journal of pathology.

[30]  M. Cutler,et al.  The Ras suppressor Rsu-1 binds to the LIM 5 domain of the adaptor protein PINCH1 and participates in adhesion-related functions. , 2005, Experimental cell research.

[31]  M. Stolte,et al.  A comparative study of E-cadherin and stromelysin-3 expression in de novo and ex adenoma carcinoma of the colorectum , 2001, Virchows Archiv.

[32]  M. Zeitz,et al.  Increased matrix metalloproteinase 2 concentration and transcript expression in advanced colorectal carcinomas , 2001, International Journal of Colorectal Disease.

[33]  T. Ng,et al.  A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  Paolo Bechi,et al.  Character of the invasive margin in colorectal cancer , 1997, Diseases of the colon and rectum.

[35]  G. Viale,et al.  Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. , 1995, Cancer research.

[36]  John E. Fothergill,et al.  Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer , 1996, Nature Medicine.

[37]  L. Bretaudeau,et al.  Induction of antigen presentation by macrophages after phagocytosis of tumour apoptotic cells. , 1998, Research in immunology.

[38]  P. Böelle,et al.  Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression , 2003, Virchows Archiv.

[39]  E C Nice,et al.  Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF‐C/D receptor VEGFR‐3 , 2001, The EMBO journal.

[40]  J. Folkman,et al.  Regulation of Angiostatin Production by Matrix Metalloproteinase-2 in a Model of Concomitant Resistance* , 1999, The Journal of Biological Chemistry.

[41]  H. Mellstedt,et al.  Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17‐1A , 2003, International journal of cancer.

[42]  J. Guillem,et al.  Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  A. Schned,et al.  Dendritic Cell Infiltration in Colon Cancer , 2001, Journal of immunotherapy.

[44]  K. Chayama,et al.  Clinical significance of angiogenesis in rectal carcinoid tumors. , 2002, Oncology reports.

[45]  H. Höfler,et al.  Stromelysin‐3 (ST‐3) mRNA Expression in Colorectal Carcinomas: Localization and Clinicopathologic Correlations , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[46]  K. Burridge,et al.  Focal adhesions, contractility, and signaling. , 1996, Annual review of cell and developmental biology.

[47]  N. Minagawa,et al.  Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer. , 2002, Anticancer research.

[48]  Thomas Hawighorst,et al.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis , 2001, Nature Medicine.

[49]  R. Flavell,et al.  Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells , 2001, Nature Medicine.

[50]  S. Miyagawa,et al.  Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer. , 2004, Human pathology.

[51]  G. Vrensen,et al.  VEGFR‐3 in adult angiogenesis , 2001, The Journal of pathology.

[52]  Marina Ziche,et al.  VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant , 2004, Cancer Research.

[53]  S. H. van der Burg,et al.  Prognostic Value of Tumor-Infiltrating Dendritic Cells in Colorectal Cancer: Role of Maturation Status and Intratumoral Localization , 2005, Clinical Cancer Research.

[54]  Van Blerk,et al.  Lymphoid infiltration and prognosis in colorectal carcinoma , 1984, British Journal of Cancer.

[55]  Y. Tu,et al.  Nck-2, a novel Src homology2/3-containing adaptor protein that interacts with the LIM-only protein PINCH and components of growth factor receptor kinase-signaling pathways. , 1998, Molecular biology of the cell.

[56]  E. Benjamini,et al.  The immunoregulatory role of antigen-antibody complexes. I. Assessment of B and T-cell responses. , 1980, Immunology.

[57]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[58]  J. Weyler,et al.  Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer , 1999, British Journal of Cancer.

[59]  Steven A. Stacker,et al.  VEGF-D promotes the metastatic spread of tumor cells via the lymphatics , 2001, Nature Medicine.

[60]  R. Altman,et al.  Wild Type and Mutant p53 Differentially Regulate the Gene Expression of Human Collagenase-3 (hMMP-13)* , 2000, The Journal of Biological Chemistry.

[61]  Xiao-Feng Sun,et al.  Clinicopathological Significance of Stromelysin-3 Expression in Colorectal Cancer , 2004, Oncology.

[62]  E. Ehler,et al.  PINCH2 is a new five LIM domain protein, homologous to PINCHand localized to focal adhesions. , 2003, Experimental cell research.

[63]  P. Chambon,et al.  Stromelysin-3 gene expression in human cancer: an overview. , 1994, Invasion & metastasis.

[64]  R. Stenling,et al.  Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors , 2002, International Journal of Colorectal Disease.

[65]  J. Varani Interaction of tumor cells with the extracellular matrix. , 1987, Revisiones sobre biologia celular : RBC.

[66]  K. Hayashi,et al.  Vascular Endothelial Growth Factor Messenger RNA Expression Level Is Preserved in Liver Metastases Compared with Corresponding Primary Colorectal Cancer , 2006, Clinical Cancer Research.

[67]  Zhi-xiang Shen,et al.  Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. , 2005, World journal of gastroenterology.

[68]  Michihiko Yoshida,et al.  A Novel Integrin-Linked Kinase–Binding Protein, Affixin, Is Involved in the Early Stage of Cell–Substrate Interaction , 2001, The Journal of cell biology.

[69]  I. Nagtegaal,et al.  Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study , 2001, BMC Cancer.

[70]  S. Hong,et al.  Tumor Angiogenesis as a Prognostic Predictor in Colorectal Carcinoma with Special Reference to Mode of Metastasis and Recurrence , 1998, Oncology.

[71]  N. Minagawa,et al.  Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancer. , 2003, Anticancer research.

[72]  A. Kossakowska,et al.  Expression Pattern of Metalloproteinases and Their Inhibitors Changes with the Progression of Human Sporadic Colorectal Neoplasia , 1993, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[73]  A. van den Hooff Stromal involvement in malignant growth. , 1988, Advances in cancer research.

[74]  T. Wobbes,et al.  Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients , 2004, International journal of cancer.

[75]  R. Flavell,et al.  Immune-Mediated Eradication of Tumors through the Blockade of Transforming Growth Factor-beta Signaling in T Cells , 2002 .

[76]  O. Kockar,et al.  Global Fibrinolytic Capacity Increased Exponentially in Metastatic Colorectal Cancer , 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[77]  D. Carbone,et al.  Erratum: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells (Nature Medicine 2, 1096-1103 (1996)) , 1996 .

[78]  A. Harris,et al.  Inclusion of Vasculature-Related Variables in the Dukes Staging System of Colon Cancer , 2005, Clinical Cancer Research.

[79]  A. Rearden A new LIM protein containing an autoepitope homologous to "senescent cell antigen". , 1994, Biochemical and biophysical research communications.

[80]  T. Monden,et al.  Use of fibrinogen to enhance the antitumor effect of OK‐432. A new approach to immunotherapy for colorectal carcinoma , 1992, Cancer.

[81]  Yun Hua,et al.  A New Focal Adhesion Protein That Interacts with Integrin-Linked Kinase and Regulates Cell Adhesion and Spreading , 2001, The Journal of cell biology.

[82]  Y. Oshika,et al.  © 1998 Cancer Research Campaign , 2022 .

[83]  R. Steele,et al.  Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy. , 1998, British Journal of Cancer.

[84]  X. Zhou,et al.  Surgical treatment and late results in 1226 cases of colorectal cancer , 1983, Diseases of the colon and rectum.

[85]  P. Basset,et al.  Structure and Promoter Characterization of the Human Stromelysin-3 Gene (*) , 1995, The Journal of Biological Chemistry.

[86]  S. Dedhar,et al.  Inhibition of integrin linked kinase (ILK) suppresses β-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC−/− human colon carcinoma cells , 2001, Oncogene.

[87]  J. Wood,et al.  Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[88]  G. Lip,et al.  The hypercoagulable state of malignancy: pathogenesis and current debate. , 2002, Neoplasia.

[89]  S. Pillai,et al.  Innate immunity. , 1996, Current opinion in immunology.

[90]  K. Okita,et al.  Relationship between matrix metalloproteinase-7 and pit pattern in early stage colorectal cancer. , 2004, Gastrointestinal endoscopy.

[91]  P. Basset,et al.  Assignment of the human stromelysin 3 (STMY3) gene to the q11.2 region of chromosome 22. , 1992, Genomics.

[92]  H. Saito,et al.  Effects of super-extended paraaortic lymphadenectomy (PAL) on biological responses in totally gastrectomized patients with T3 or T4 gastric cancer , 1998, Gastric Cancer.

[93]  I. Talbot,et al.  Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. , 1996, Cancer research.

[94]  H. Spjut,et al.  Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma , 1967, Cancer.

[95]  S. Leurgans,et al.  Tumor Angiogenesis as a Predictor of Recurrence and Survival in Patients with Node‐Negative Colon Cancer , 1995, Annals of surgery.

[96]  C. McArdle,et al.  Tumour T-lymphocyte subset infiltration and tumour recurrence following curative resection for colorectal cancer. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[97]  T. Bauer,et al.  Ki‐67‐determined growth fraction versus standard staging and grading parameters in colorectal carcinoma: A multivariate analysis , 1992, Cancer.

[98]  Y. Maehara,et al.  Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues , 2000, British Journal of Cancer.

[99]  R. Schwendener,et al.  Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy. , 2006, Cancer letters.

[100]  K. Chayama,et al.  Clinical Significance of Vascular Endothelial Growth Factor C Expression and Angiogenesis at the Deepest Invasive Site of Advanced Colorectal Carcinoma , 2002, Oncology.

[101]  L. Devy,et al.  Emerging roles for proteinases in cancer. , 1997, Invasion & metastasis.

[102]  D. Murray,et al.  Prognosis in colon cancer: a pathologic reassessment. , 1975, Archives of surgery.

[103]  S. Kawasaki,et al.  Morphometric analysis of liver macrophages in patients with colorectal liver metastasis , 2004, Clinical & Experimental Metastasis.

[104]  Z. Werb,et al.  ECM signalling: orchestrating cell behaviour and misbehaviour. , 1998, Trends in cell biology.

[105]  B. Yasar,et al.  Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[106]  Lida Guo,et al.  Regulation of fibronectin matrix deposition and cell proliferation by the PINCH‐ILK‐CH‐ILKBP complex , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[107]  Y. Tu,et al.  The LIM-Only Protein PINCH Directly Interacts with Integrin-Linked Kinase and Is Recruited to Integrin-Rich Sites in Spreading Cells , 1999, Molecular and Cellular Biology.

[108]  Hong Zhang,et al.  Relationships of tumor inflammatory infiltration and necrosis with microsatellite instability in colorectal cancers. , 2005, World journal of gastroenterology.

[109]  M. Langenskiöld,et al.  Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer , 2005, International Journal of Colorectal Disease.

[110]  J. Folkman What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[111]  V. Kosma,et al.  Prognostic value of tumour‐infiltrating lymphocytes (TILs) in colorectal cancer , 1997, The Journal of pathology.

[112]  F. O'Malley,et al.  Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. , 1996, The American journal of surgical pathology.

[113]  S. Kumar,et al.  Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis , 2003, British Journal of Cancer.

[114]  I. Okayasu,et al.  Enzyme histochemical analysis of lymphatic vessels in colon carcinoma: occurrence of lymphangiogenesis within the tumor. , 2005, Hepato-gastroenterology.

[115]  A. Giatromanolaki,et al.  “Stromatogenesis” and Tumor Progression , 2004, International journal of surgical pathology.

[116]  W. Schürch,et al.  Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[117]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[118]  B. C. Patterson,et al.  Angiostatin-converting Enzyme Activities of Human Matrilysin (MMP-7) and Gelatinase B/Type IV Collagenase (MMP-9)* , 1997, The Journal of Biological Chemistry.

[119]  Meera Mathur,et al.  Stromelysin‐3 expression is an early event in human oral tumorigenesis , 2003, International journal of cancer.

[120]  K. Chayama,et al.  Clinical Significance of Angiogenic Factor Expression at the Deepest Invasive Site of Advanced Colorectal Carcinoma , 2002, Oncology.

[121]  Scott Kurtzman,et al.  Angiogenesis in normal tissue adjacent to colon cancer , 1998, Journal of surgical oncology.

[122]  A. Wellmann,et al.  Stromal expression of invasion‐promoting, matrix‐degrading proteases MMP‐1 and ‐9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers , 2003, International journal of cancer.

[123]  P. Gold Immunology and immunotherapy of colorectal cancer. , 1978, Canadian journal of surgery. Journal canadien de chirurgie.

[124]  C. Sautès-Fridman,et al.  High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. , 2001, Cancer research.

[125]  E. Roeb,et al.  Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas , 2004, International Journal of Colorectal Disease.

[126]  J. Marshall,et al.  A Phase I Study of Oral BMS-275291, a Novel Nonhydroxamate Sheddase-Sparing Matrix Metalloproteinase Inhibitor, in Patients with Advanced or Metastatic Cancer , 2004, Clinical Cancer Research.

[127]  M. Pollán,et al.  Histopathologic prognostic score in colorectal adenocarcinomas. , 1998, Anticancer Research.

[128]  Gary Ruvkun,et al.  A Conserved LIM Protein That Affects Muscular Adherens Junction Integrity and Mechanosensory Function in Caenorhabditis elegans , 1999, The Journal of cell biology.

[129]  L. Jurata,et al.  Structure and function of LIM domains. , 1998, Current topics in microbiology and immunology.

[130]  M. Heymann,et al.  Immunomodulatory effects of tumor‐associated fibroblasts in colorectal‐tumor development , 1999, International journal of cancer.

[131]  B. Bussolati,et al.  Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. , 2001, The American journal of pathology.

[132]  J. Wang-Rodriguez,et al.  The signaling adapter protein PINCH is up‐regulated in the stroma of common cancers, notably at invasive edges , 2002, Cancer.

[133]  A. Mori,et al.  Absence of Smooth Muscle Actin-Positive Pericyte Coverage of Tumor Vessels Correlates with Hematogenous Metastasis and Prognosis of Colorectal Cancer Patients , 2005, Oncology.

[134]  M. Enjoji,et al.  Histopathologic evaluation of survival time in patients with colorectal carcinoma , 1989, Journal of surgical oncology.

[135]  K. Saito,et al.  Expression of costimulatory molecules B7-1 and B7-2 by macrophages along invasive margin of colon cancer: a possible antitumor immunity? , 1997, Laboratory investigation; a journal of technical methods and pathology.

[136]  M. Fernández-Aceñero,et al.  Prognostic significance of microvascular counts in rectal carcinoma. , 2000, Pathology, research and practice.

[137]  E. Bergsland Vascular endothelial growth factor as a therapeutic target in cancer. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[138]  S. Eccles,et al.  VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. , 2001, Neoplasia.

[139]  R. Longo,et al.  Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. , 1998, British Journal of Cancer.

[140]  Y. Tu,et al.  Distinct Roles of Two Structurally Closely Related Focal Adhesion Proteins, α-Parvins and β-Parvins, in Regulation of Cell Morphology and Survival* , 2004, Journal of Biological Chemistry.

[141]  J. Jass Lymphocytic infiltration and survival in rectal cancer. , 1986, Journal of clinical pathology.

[142]  Xiao-Feng Sun,et al.  Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy. , 2006, International journal of radiation oncology, biology, physics.

[143]  K. Rubin,et al.  Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage. , 1997, British Journal of Cancer.

[144]  Christopher J. Robinson,et al.  The splice variants of vascular endothelial growth factor (VEGF) and their receptors. , 2001, Journal of cell science.

[145]  S. Dedhar,et al.  Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase , 1996, Nature.

[146]  M. Mori,et al.  S‐100 protein‐positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis , 1989, Cancer.

[147]  W. Hohenberger,et al.  Angiogenesis and dendritic cell density are not correlated with metachronous distant metastasis in curatively operated rectal cancer , 2003, International Journal of Colorectal Disease.

[148]  Lida Guo,et al.  A Critical Role of the PINCH-Integrin-linked Kinase Interaction in the Regulation of Cell Shape Change and Migration* , 2002, The Journal of Biological Chemistry.

[149]  S. Akiba,et al.  Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma , 1996, Cancer.

[150]  K. Chayama,et al.  Expression of VEGF‐C and VEGF‐D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma , 2004, Cancer science.

[151]  Masaichi Ogawa,et al.  Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach. , 2005, Hepato-gastroenterology.

[152]  R. Laing,et al.  Feasibility of new prognostic classification for rectal cancer. , 1988, Journal of clinical pathology.

[153]  Rakesh K Jain,et al.  Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. , 2002, The American journal of pathology.

[154]  R. Whitehouse,et al.  Tumor angiogenesis in stage II colorectal carcinoma: association with survival. , 1998, American journal of clinical pathology.

[155]  S. Arii,et al.  Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma , 2000, Cancer.

[156]  H. Nielsen,et al.  Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue , 1999, The Journal of pathology.

[157]  H. Denk,et al.  Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer , 2004, Virchows Archiv.

[158]  M. J. Fernández Aceñero,et al.  Vascular enumeration as a prognosticator for colorectal carcinoma. , 2000, European journal of cancer.

[159]  W. Stetler-Stevenson,et al.  Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. , 1996, Seminars in cancer biology.

[160]  宮本 心一 Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein-3 , 2004 .

[161]  J. Harmey,et al.  Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF) , 2005, Journal of cellular and molecular medicine.

[162]  Y. Atomi,et al.  Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas , 2001, British Journal of Cancer.

[163]  N. Brown,et al.  Proteolysis in colorectal cancer. , 1999, Molecular pathology : MP.

[164]  M. Yamakawa,et al.  Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma , 2002, The Journal of pathology.

[165]  P. Mingazzini,et al.  The influence of tumor lymphocytic infiltration on long term survival of surgically treated colorectal cancer patients. , 1992, International surgery.

[166]  A. Jubb,et al.  Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[167]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[168]  A. Khorana,et al.  Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma , 2003, Cancer.

[169]  J. Burke,et al.  Fine structure of the lymphatic capillary and the adjoining connective tissue area. , 1966, The American journal of anatomy.

[170]  K. Yoshimura,et al.  Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection , 2003, Journal of surgical oncology.

[171]  N. Minagawa,et al.  Relationship between interleukin-12-expressing cells and antigen-presenting cells in patients with colorectal cancer. , 2005, Anticancer research.

[172]  S. Takeno,et al.  Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. , 2003, Oncology reports.

[173]  F. Cianchi,et al.  Tumor angiogenesis in lymph node-negative rectal cancer: Correlation with clinicopathological parameters and prognosis , 2002, Annals of Surgical Oncology.

[174]  C. Miki,et al.  Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma , 2000, American Journal of Gastroenterology.

[175]  Rakesh K Jain,et al.  Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.

[176]  R. Tollenaar,et al.  Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells , 2004, Cancer Immunology, Immunotherapy.

[177]  J. J. Breen,et al.  LIM domains: multiple roles as adapters and functional modifiers in protein interactions. , 1998, Trends in genetics : TIG.

[178]  W. Jiang,et al.  Prognostic values of tumor endothelial markers in patients with colorectal cancer. , 2005, World journal of gastroenterology.

[179]  E. Thorsby,et al.  p21‐ras‐peptide‐specific T‐cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly → Asp) , 2007, International journal of cancer.

[180]  C. Meininger Mast cells and tumor-associated angiogenesis. , 1995, Chemical immunology.

[181]  Jian-ping Wang,et al.  [Correlation of lymphangiogenesis to progression of colorectal cancer]. , 2005, Ai zheng = Aizheng = Chinese journal of cancer.

[182]  W. Jiang,et al.  Quantitative analysis of lymphangiogenic markers in human colorectal cancer. , 2003, International journal of oncology.

[183]  M. Koutsilieris,et al.  Mast cell-tumor cell interactions: for or against tumour growth and metastasis? , 1997, Anticancer research.

[184]  Y. Tu,et al.  Distinct roles of two structurally closely related focal adhesion proteins, alpha-parvins and beta-parvins, in regulation of cell morphology and survival. , 2004, The Journal of biological chemistry.

[185]  S. Chakraborti,et al.  Regulation of matrix metalloproteinases: An overview , 2003, Molecular and Cellular Biochemistry.

[186]  B. Bodey,et al.  Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas. , 2000, In Vivo.

[187]  S. Dedhar,et al.  Integrin-linked Protein Kinase Regulates Fibronectin Matrix Assembly, E-cadherin Expression, and Tumorigenicity* , 1998, The Journal of Biological Chemistry.

[188]  L. Ellis,et al.  Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. , 1995, Cancer research.

[189]  A. Parker,et al.  Expression profiling of metalloproteinases and their inhibitors in cartilage. , 2004, Arthritis and rheumatism.

[190]  P. Chambon,et al.  Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin‐3 and BM‐40/SPARC genes , 1995, International journal of cancer.

[191]  M. Barbacid,et al.  Identification of Insulin-like Growth Factor-binding Protein-1 as a Potential Physiological Substrate for Human Stromelysin-3* , 1997, The Journal of Biological Chemistry.

[192]  M. D. Della Porta,et al.  Dendritic Cells and Vascular Endothelial Growth Factor in Colorectal Cancer: Correlations with Clinicobiological Findings , 2005, Oncology.

[193]  G. Jayson,et al.  Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy , 2003, British Journal of Cancer.

[194]  D. Leaper,et al.  Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging , 2000, The British journal of surgery.

[195]  A. Harris,et al.  Combined role of tumor angiogenesis, bcl‐2, and p53 expression in the prognosis of patients with colorectal carcinoma , 1999, Cancer.

[196]  E. Chinelli,et al.  Prognostic correlations of operable carcinoma of the rectum , 1985, Diseases of the Colon & Rectum.

[197]  A. House,et al.  Colonic carcinoma. A quantitative assessment of lymphocyte infiltration at the periphery of colonic tumors related to prognosis , 1978, Cancer.

[198]  H. Ohtani,et al.  Close Association between Fas Ligand (FasL; CD95L)‐positive Tumor‐associated Macrophages and Apoptotic Cancer Cells along Invasive Margin of Colorectal Carcinoma: A Proposal on Tumor‐Host Interactions , 2002, Japanese journal of cancer research : Gann.

[199]  M. Mandalà,et al.  Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1. , 2001, Journal of biological regulators and homeostatic agents.

[200]  A. Küpelioğlu,et al.  Matrix metalloproteinase‐9,‐3 and tissue inhibitor of matrix metalloproteinase‐1 in colorectal cancer: relationship to clinicopathological variables , 2007, Cell biochemistry and function.

[201]  K. Ikari,et al.  Matrix metalloproteinase 28/epilysin expression in cartilage from patients with rheumatoid arthritis and osteoarthritis: comment on the article by Kevorkian et al. , 2004, Arthritis and rheumatism.

[202]  Meit A. Björndahl Lymphangiogenesis and lymphatic metastasis , 2005 .

[203]  J. Gille Antiangiogenic cancer therapies get their act together: current developments and future prospects of growth factor‐ and growth factor receptor‐targeted approaches , 2006, Experimental dermatology.

[204]  J. Sloan,et al.  A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin , 2005, Anti-cancer drugs.

[205]  C. López-Otín,et al.  Differential Expression of Three Matrix Metalloproteinases, MMP-19, MMP-26, and MMP-28, in Normal and Inflamed Intestine and Colon Cancer , 2004, Digestive Diseases and Sciences.

[206]  H. Putter,et al.  Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis , 2004, Laboratory Investigation.

[207]  H. Ohtani,et al.  Stromal Expression of MMP‐9 and Urokinase Receptor Is Inversely Associated with Liver Metastasis and with Infiltrating Growth in Human Colorectal Cancer: A Novel Approach from Immune/Inflammatory Aspect , 1997, Japanese journal of cancer research : Gann.

[208]  Lida Guo,et al.  Characterization of PINCH-2, a New Focal Adhesion Protein That Regulates the PINCH-1-ILK Interaction, Cell Spreading, and Migration* , 2002, The Journal of Biological Chemistry.

[209]  S. Leung,et al.  Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon. , 1998, Human pathology.

[210]  H. Höfler,et al.  Stromelysin-3 expression in early (pT1) carcinomas and pseudoinvasive lesions of the colorectum , 1997, Virchows Archiv.

[211]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[212]  M. Oya,et al.  High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. , 2001, Japanese journal of clinical oncology.

[213]  J. McKay,et al.  Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer , 2002, Journal of clinical pathology.

[214]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[215]  G. Karakiulakis,et al.  Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon. , 1997, Invasion & metastasis.

[216]  R. Gausas,et al.  Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. , 2004, Oncology reports.

[217]  R. vander Zwaag,et al.  From Dukes through Jass: pathological prognostic indicators in rectal cancer. , 1994, Human pathology.